%0 Journal Article
%T Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model
%A Valentina Bordignon
%A Paola Cordiali-Fei
%A Monica Rinaldi
%A Emanuela Signori
%A Andrea Cottarelli
%A Manuela Zonfrillo
%A Fabrizio Ensoli
%A Guido Rasi
%A Maria Fuggetta
%J Journal of Experimental & Clinical Cancer Research
%D 2012
%I BioMed Central
%R 10.1186/1756-9966-31-9
%X Here we show a simple and reproducible assay for the evaluation of antigen-specific CD8+ cytotoxic T lymphocytes based on a LysiSpot technique for the simultaneous determination of antigen-specific IFN-¦Ã production and assessment of tumor cytolysis. The assay was developed within an experimental model of colorectal carcinoma, induced by the colorectal tumor cell line DHD-K12 that induces tumors in BDIX rats and, in turn, elicits a tumor- specific immune response.Using DHD-K12 cells transfected to express Escherichia coli ¦Â-galactosidase as target cells, and by the fine setting of spot colours detection, we have developed an in vitro assay that allows the recognition of cytotoxic T lymphocytes induced in BDIX rats as well as the assessment of anti-tumour cytotoxicity. The method highlighted that in the present experimental model the tumour antigen-specific immune response was bound to killing target cells in the proportion of 55%, while 45% of activated cells were not cytotoxic but released IFN-¦Ã. Moreover in this model by an ELISPOT assay we demonstrated the specific recognition of a nonapeptide epitope called CSH-275 constitutionally express in DHD-K12 cells.The assay proved to be highly sensitive and specific, detecting even low frequencies of cytotoxic/activated cells and providing the evaluation of cytokine-expressing T cells as well as the extent of cytotoxicity against the target cells as independent functions. This assay may represent an important tool to be adopted in experimental settings including the development of vaccines or immune therapeutic strategiesA major effort in the tumour immunology research area is directed to the identification of tumor antigens for the development of specific anti-tumour immune therapies. Several putative anti-cancer vaccines have been studied in animal models through immunization with intact tumour cells, cancer-related peptides, Ag-loaded dendritic cells (DCs), different viral delivery systems as well as vaccines combined
%K LysiSpot
%K ELISpot
%K Tumor antigens
%K CTLs
%K BDIX rats
%K Colon cancer
%U http://www.jeccr.com/content/31/1/9